Amino Acid Metabolism Disorders Treatment Market anticipated to grow at a 6.2% CAGR and reach USD 1.39 Billion by 2032 | FMI

Posted on 2024-08-01 by Future Market Insights in Healthcare, Pharmaceuticals // 0 Comments

Amino Acid Metabolism Disorders Treatment Market

The treatment landscape for the Amino Acid Metabolism Disorders Treatment Market is undergoing a positive transformation. A recent analysis projects the global market size to reach over USD 1.39 billion by 2032, reflecting a steady Compound Annual Growth Rate (CAGR) of 6.2%. This significant growth builds on the current market value of over USD 814.27 million in 2022.

Start Exploring Now – Download Your Complimentary Visuals Report!

According to Future Market Insights, the global amino acid metabolism disorders treatment market is expected to rise at a CAGR of 6.4% from 2017 to 2026. The market is projected to touch a valuation of over US$1,030 Mn by the end of the forecast period.

Key Insights on Amino Acid Metabolism Disorders Treatment Market

Based on region, the global amino acid metabolism disorders treatment market has been segmented into North America, Europe, Latin America, Asia Pacific except Japan, Japan, and the Middle East and Africa. Amongst these, North America is expected to retain a leading position in the market by the end of the forecast period reaching a valuation of over US$359 Mn. North America is expected to be closely followed by Europe. Players operating in this market can seek potential opportunities from the U.S., Germany, Spain, and France owing to several clinical trials taking place on this treatment and several mergers and acquisitions occurring among core players operating in these regions. Players can also find lucrative opportunities from Asia Pacific excluding Japan and as well with the rise in nutritional management activities in these regions. Countries in APAC such as China and India are also expected to emerge as potential adopters of amino acid metabolism disorders treatment in the long run.

Unlock Your Savings – Click Here for the Discount.

In terms of product type, the global amino acid metabolism disorder treatment market has been segmented into arginine, folic acid, vitamin B6 and B12, thiamine, vitamin D, betaine, carglumic acid, sapropterin dihydrocholoride, and others. Among these, carglumic acid is expected to lead the market until the end of the forecast period reaching a valuation of over US$185 Mn. However, sapropterin dihydrocholoride is expected to witness the maximum growth rate over the course of the forecast period.

Based on indication, the global market for amino acid metabolism disorder treatment has been classified into phenylketonuria, maple syrup urine disease, argininosuccinic acidemia, citrullinemia, and homocystinuria. Among all of these, phenylketonuria is expected to emerge dominant by the end of the forecast period.

Based on sales channel, the global market for amino acid metabolism disorder treatment has been classified into hospital pharmacies, retail pharmacies, and online sales. Hospital pharmacies is expected to take the lead among all these by the end of the forecast period.

Vendor Landscape

The companies operating in the market are Pfizer, Inc., GlaxoSmithKline PLC, Merck KGaA, Koninklijke DSM N.V., Recordati S.p.A., Sanofi, Civentichem, LLC, Shine Star (Hubei) Biological Engineering Co., Ltd., AMINO GmbH, and Kyowa Hakko Kirin Co., Ltd.

Transform Your Approach: Download the Customized Report.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Matched content

Editor’s pick